A detailed history of Credit Suisse Ag transactions in Absci Corp stock. As of the latest transaction made, Credit Suisse Ag holds 21,920 shares of ABSI stock, worth $65,540. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,920
Previous 21,920 -0.0%
Holding current value
$65,540
Previous $92,000 34.78%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$1.15 - $4.79 $1,178 - $4,909
-1,025 Reduced 4.47%
21,920 $92,000
Q3 2023

Nov 13, 2023

BUY
$1.28 - $2.41 $8,070 - $15,195
6,305 Added 37.89%
22,945 $30,000
Q2 2023

Aug 11, 2023

BUY
$1.17 - $2.03 $19,468 - $33,779
16,640 New
16,640 $25,000
Q4 2022

Feb 13, 2023

BUY
$2.0 - $3.58 $86 - $153
43 Added 1.38%
3,152 $6,000
Q3 2022

Nov 10, 2022

BUY
$2.95 - $4.83 $716 - $1,173
243 Added 8.48%
3,109 $10,000
Q2 2022

Aug 12, 2022

BUY
$3.13 - $8.83 $8,970 - $25,306
2,866 New
2,866 $9,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $278M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.